Altavista Wealth Management’s Boston Scientific BSX Stock Holding History

Altavista Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$255K	Hold	6,000	–	–	0.05%	172
2021 Q3	$260K	Hold	6,000	–	–	0.06%	165
2021 Q2	$257K	Hold	6,000	–	–	0.06%	166
2021 Q1	$232K	Hold	6,000	–	–	0.06%	164
2020 Q4	$216K	Hold	6,000	–	–	0.05%	163
2020 Q3	$229K	Sell	6,000 -98	-2%	-$3.78K	0.06%	153
2020 Q2	$214K	Buy	+6,098	New	+$220K	0.06%	163
2020 Q1	–	Sell	-6,098	Closed	-$276K	–	157
2019 Q4	$276K	Hold	6,098	–	–	0.08%	143
2019 Q3	$248K	Hold	6,098	–	–	0.08%	146
2019 Q2	$262K	Sell	6,098 -222	-4%	-$8.54K	0.08%	134
2019 Q1	$243K	Buy	6,320 +222	+4%	+$8.48K	0.09%	135
2018 Q4	$216K	Hold	6,098	–	–	0.09%	140
2018 Q3	$235K	Buy	+6,098	New	+$213K	0.09%	140

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Altavista Wealth Management's BSX Position: Q4 2021 in Review

Altavista Wealth Management held its Boston Scientific (BSX) position steady in Q4 2021 at 6,000 shares worth $255K. The position accounts for 0.05% of the portfolio, ranked #172.

Altavista Wealth Management first reported a position in BSX in Q3 2018 and has held it in 13 quarters since. The position peaked at $276K in Q4 2019. 889 funds tracked by Wall St. Rank hold BSX as of Q4 2021.

Altavista Wealth Management held 6,000 shares of Boston Scientific worth $255K as of Q4 2021.
Altavista Wealth Management left its Boston Scientific share count unchanged in Q4 2021.
Boston Scientific made up 0.05% of Altavista Wealth Management's portfolio in Q4 2021, its #172 holding.
Altavista Wealth Management first reported a position in Boston Scientific in Q3 2018 and has held it in 13 quarters since.
Altavista Wealth Management's Boston Scientific position peaked at $276K in Q4 2019.
889 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2021.

Based on Altavista Wealth Management's 13F filing for Q4 2021, filed 14 Feb 2022.